SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the second quarter ended June 30, 2023. “We made significant advancements…Read More
Singular Genomics Systems Inc Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results
